Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 12, 2011, Pages 4852-4857

  Antonyak, Marc A ^a   Li, Bo ^a   Boroughs, Lindsey K ^a   Johnson, Jared L ^a   Druso, Joseph E ^a   Bryant, Kirsten L ^a   Holowka, David A ^a   Cerione, Richard A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cancer progression; Extracellular matrix; Oncosomes; Shedding vesicles; Tumor microenvironment

Indexed keywords

FIBRONECTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CELL TRANSFORMATION; CELL VACUOLE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MICROVESICLE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEOMICS; RECIPIENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELL-DERIVED MICROPARTICLES; EPITHELIAL CELLS; FIBROBLASTS; FIBRONECTINS; HELA CELLS; HUMANS; MICE; NEOPLASMS; NIH 3T3 CELLS; TRANSGLUTAMINASES;

EID: 79953229234     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1017667108     Document Type: Article

References (30)

1. Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: Messengers and mediators of tumor progression. Cell Cycle 8:2014-2018.
2. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: Artefacts no more. Trends Cell Biol 19:43-51.
3. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ (2006) Membrane-derived microvesicles: Important and underappreciated mediators of cellto- cell communication. Leukemia 20:1487-1495. (Pubitemid 44264090)
4. Skog J, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476.
5. Al-Nedawi K, et al. (2008) Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:619-624. (Pubitemid 351627382)
6. Graner MW, et al. (2009) Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 23:1541-1557.
7. Di Vizio D, et al. (2009) Oncosome formation in prostate cancer: Association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69: 5601-5609.
8. Mathivanan S, Simpson RJ (2009) ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9:4997-5000.
9. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J (2009) Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:3794-3799.
10. Li B, et al. (2010) EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc Natl Acad Sci USA 107: 1408-1413.
11. Yamaguchi H, Wang HG (2006) Tissue transglutaminase serves as an inhibitor of apoptosis by cross-linking caspase 3 in thapsigargin-treated cells. Mol Cell Biol 26: 569-579. (Pubitemid 43089769)
12. Hwang JY, et al. (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res 68:5849-5858.
13. Mann AP, et al. (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: Delineation of a novel pathway. Cancer Res 66:8788-8795. (Pubitemid 44449196)
14. Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26:2459-2470. (Pubitemid 46597265)
15. Yuan L, et al. (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26:2563-2573. (Pubitemid 46632005)
16. Balklava Z, et al. (2002) Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: The active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem 277:16567-16575. (Pubitemid 34967673)
17. Akimov SS, Krylov D, Fleischman LF, Belkin AM (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148:825-838.
18. Feng Y, et al. (2003) Exo1: A new chemical inhibitor of the exocytic pathway. Proc Natl Acad Sci USA 100:6469-6474. (Pubitemid 36666605)
19. Gaudry CA, et al. (1999) Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem 274:30707-30714.
20. Yang W, Lin Q, Guan JL, Cerione RA (1999) Activation of the Cdc42-associated tyrosine kinase-2 (ACK-2) by cell adhesion via integrin beta1. J Biol Chem 274: 8524-8530. (Pubitemid 29164642)
21. Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238:491-497. (Pubitemid 17147032)
22. Wierzbicka-Patynowski I, Schwarzbauer JE (2003) The ins and outs of fibronectin matrix assembly. J Cell Sci 116:3269-3276. (Pubitemid 37038975)
23. Leiss M, Beckmann K, Girós A, Costell M, Fässler R (2008) The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr Opin Cell Biol 20:502-507.
24. Shao M, et al. (2009) Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res 69:9192-9201.
25. Hettasch JM, et al. (1996) Tissue transglutaminase expression in human breast cancer. Lab Invest 75:637-645. (Pubitemid 26392795)
26. Singer CF, et al. (2006) Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer. Clin Exp Metastasis 23:33-39. (Pubitemid 44576777)
27. Williams CM, Engler AJ, Slone RD, Galante LL, Schwarzbauer JE (2008) Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res 68:3185-3192.
28. Barkan D, et al. (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68:6241-6250.
29. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535. (Pubitemid 30625739)
30. Antonyak MA, et al. (2004) Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem 279:41461-41467. (Pubitemid 39313586)